Thrombotic Thrombocytopenic Purpura (TTP) is a rare disorder caused by an enzyme deficiency. This can be heriditary or can be acquired as an autoimmune condition.
Thrombotic Thrombocytopenic Purpura (TTP) is a rare disorder caused by an enzyme deficiency. This can be heriditary or can be acquired as an autoimmune condition.
Quanterix Corporation, a leader in the transformation of healthcare through its ultrasensitive single molecule testing capabilities, has announced that Analytical Chemistry, a leading peer-reviewed...
Quanterix Corporation, a leader in the transformation of healthcare through its ultrasensitive single molecule testing capabilities, has announced that Analytical Chemistry, a leading peer-reviewed...
Could 'barring exit from blood vessels' stop breast cancer spread?
2/11/2016
A new study suggests it may be possible to stop breast cancer spread via the bloodstream by disrupting the signals cancer cells exchange with cells in the lining of blood vessels.
Scientists find leukemia's surroundings key to its growth
2/11/2016
Researchers at The University of Texas at Austin have discovered that a type of cancer found primarily in children can grow only when signaled to do so by other nearby cells that are noncancerous.
Scientists find leukemia's surroundings key to its growth
2/11/2016
Researchers at The University of Texas at Austin have discovered that a type of cancer found primarily in children can grow only when signaled to do so by other nearby cells that are noncancerous.
Attention problems persist in childhood leukemia survivors treated with chemotherapy alone
2/11/2016
Pediatric acute lymphoblastic leukemia (ALL) patients treated with chemotherapy alone remain at risk for attention and learning problems that persist after treatment ends, according to St.
Attention problems persist in childhood leukemia survivors treated with chemotherapy alone
2/11/2016
Pediatric acute lymphoblastic leukemia (ALL) patients treated with chemotherapy alone remain at risk for attention and learning problems that persist after treatment ends, according to St.
Nanoparticle reduces targeted cancer drug's toxicity
2/11/2016
In one of the first efforts to date to apply nanotechnology to targeted cancer therapeutics, researchers have created a nanoparticle formulation of a cancer drug that is both effective and nontoxic...
